NextDocs

About NextDocs

Founded in 2006 by Zikria Syed and Matt Walz, NextDocs established itself as a provider of compliance and document management software solutions tailored for the life sciences sector. Syed, with a background that includes roles at Microsoft and Siemens Medical Systems and as CEO of clinical trial management software company Broadpeak, brought significant industry experience to the venture. Walz holds an M.B.A. and a B.S. in Computer Science from the University of Delaware.

The company's core business revolves around providing software that assists pharmaceutical, biotechnology, and medical device companies in adhering to regulations from bodies like the FDA and EMA. This is achieved by automating and streamlining processes related to regulatory documents, quality management, and clinical trials, thereby improving efficiency and reducing costs. The software was designed to manage the entire document lifecycle, from creation and authoring to submission and archival. NextDocs offered its solutions as both on-premise and cloud-based, 100% browser-based systems, built on the Microsoft SharePoint Server platform.

The client base for NextDocs included medium to large-sized businesses within the life sciences and healthcare industries, counting some of the world's top pharmaceutical companies and clinical research organizations (CROs) among its customers. The company's revenue model was based on selling these regulated content management solutions. A significant milestone for the company was its acquisition by Aurea in June 2015. Following the acquisition, the NextDocs product was rebranded as Aurea Compliance Manager and became the core of Aurea's Life Sciences Solutions division. Prior to its acquisition, NextDocs had successfully raised a total of $28.8 million in funding over three rounds, with its Series C in 2013 bringing in $13.5 million.